Semma Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Semma Therapeutics pursues a cell-based approach to medicine, developing a new class of regenerative therapies that combines stem cell technology with delivery systems designed to shield implanted cells from the immune system. Its research focuses on pairing highly differentiated active cells with a device to pursue a functional cure for diabetes. The company is headquartered in Cambridge, MA, with operations in Providence, RI, and maintains a mid-sized team. 

Within the biotechnology research sector, Semma targets patients with diabetes by pursuing therapies that may offer durable, cell-based treatment options beyond conventional approaches. The organization concentrates on translating its regenerative medicine platform into clinically meaningful therapies that could extend or improve patient outcomes.

Sign up for free to view info

Company overview Employee directory